Literature DB >> 1689889

Acute hemodynamic effects of FK 506 during and after orthotopic liver transplantation.

Y Kang1, M A Mazer, A M DeWolf, J J Fung, T Gasior, R Venkataramanan, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1689889      PMCID： PMC2903876     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

1.  Effect of FK506 in experimental organ transplantation.

Authors:  S Todo; N Murase; Y Ueda; L Podesta; P ChapChap; D Kahn; K Okuda; O Imventarza; A Casavilla; J Demetris
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

2.  Pathological studies in canine and baboon renal allograft recipients immunosuppressed with FK-506.

Authors:  S Thiru; D S Collier; R Calne
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

3.  Toxicology of FK-506 in the Lewis rat.

Authors:  M A Nalesnik; S Todo; N Murase; S Gryzan; P H Lee; L Makowka; T E Starzl
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

4.  FK 506 for liver, kidney, and pancreas transplantation.

Authors:  T E Starzl; S Todo; J Fung; A J Demetris; R Venkataramman; A Jain
Journal:  Lancet       Date:  1989-10-28       Impact factor: 79.321
  4 in total
  2 in total

1.  The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver.

Authors:  K Abu-Elmagd; J J Fung; M Alessiani; A Jain; R Venkataramanan; V S Warty; S Takaya; S Todo; W D Shannon; T E Starzl
Journal:  Transplantation       Date:  1991-07       Impact factor: 4.939

2.  What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.

Authors:  A Jain; J Reyes; R Kashyap; S Rohal; K Abu-Elmagd; T Starzl; J Fung
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.